News & Analysis as of

Research and Development Mental Health Clinical Trials

King & Spalding

Administrative, Congressional, and State Interest Signal a Potential Breakthrough Moment for Psychedelics

King & Spalding on

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, however, psychedelics have garnered scientific and public attention for their potential...more

K&L Gates LLP

Veterans Day Special Episode: Combating Traumatic Brain Injury

K&L Gates LLP on

In this special Veterans Day episode, Matt Miller is joined by Brandon Davis, of The Davis Focus Project and former Black Hawk instructor pilot in the 160th Special Operations Aviation Regiment. Brandon shares his experience...more

Husch Blackwell LLP

Advancing Military Mental Health

Husch Blackwell LLP on

Research into psychedelic-assisted therapy receives funding in the National Defense Authorization Act for Fiscal Year 2024. In an epoch marked by rapid innovation in mental health treatments, a paradigm shift is on the...more

Ballard Spahr LLP

Obama Signs 21st Century Cures Act, Adding $6.3 Billion For Medical Research

Ballard Spahr LLP on

The Cures Act aims to increase the speed by which new drugs are brought to market by streamlining clinical trials, allowing the use of patient data in the regulatory review process, and modernizing U.S. Food and Drug...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide